miRNA-16–5p, expressed at lower levels in type 1 diabetes mellitus (T1DM) patients, can inhibit high-glucose-induced pancreatic β-cell apoptosis by targeting CXCL10 [79]. This evidence concerns the gene CXCL10 and type 1 diabetes mellitus.